Magnum Experiment 92

The chart shows the growth of an initial investment of $10,000 in Magnum Experiment 92, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

As of Apr 11, 2026, the Magnum Experiment 92 returned 3.19% Year-To-Date and 18.93% of annualized return in the last 10 years.

Based on dividend-adjusted daily data since Apr 4, 2014, Magnum Experiment 92's average daily return is +0.07%, while the average monthly return is +1.46%. At this rate, an investment would double in approximately 4.0 years.

Historically, 70% of months were positive and 30% were negative. The best month was Apr 2020 with a return of +11.8%, while the worst month was Dec 2018 at -7.7%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 3 months.

On a daily basis, Magnum Experiment 92 closed higher 56% of trading days. The best single day was Mar 13, 2020 with a return of +9.1%, while the worst single day was Mar 16, 2020 at -10.8%.

Magnum Experiment 92 has an annualized alpha of 7.86%, beta of 0.85, and R² of 0.91 versus S&P 500 Index. Calculated based on daily prices since April 04, 2014.

• This portfolio captured 107.25% of S&P 500 Index gains but only 73.84% of its losses — a favorable profile for investors.
• This portfolio generated an annualized alpha of 7.86% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.
• With beta of 0.85 and R² of 0.91, this portfolio moves broadly in line with S&P 500 Index — much of its variation is explained by market exposure rather than independent behavior.

Magnum Experiment 92 has an expense ratio of 0.01%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Magnum Experiment 92 ranks 66 for risk / return — better than 66% of portfolios on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Magnum Experiment 92 Sharpe ratios as of Apr 11, 2026 (values are recalculated daily):

• 1-Year: 2.71
• 5-Year: 1.13
• 10-Year: 1.19
• All Time: 1.17

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 2.14 to 3.05, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of Magnum Experiment 92 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Magnum Experiment 92 provided a 1.53% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Magnum Experiment 92. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Magnum Experiment 92 was 27.59%, occurring on Mar 23, 2020. Recovery took 78 trading sessions.

The current Magnum Experiment 92 drawdown is 2.64%.

The chart below shows the rolling one-month volatility.